C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07527130
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • C11 ER176 Tracer — DRUG
    C11 ER176 tracer will be administered by IV, followed by PET imaging of the brain to evaluate for neuroinflammation

Study Details

The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.

Key Dates

Start date
May 31, 2026
Status verified
Apr 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
10 participants (estimated)

Arms

  • Arm: Post Covid Syndrome
    PET imaging through the C11 ER176 tracer

Primary Outcome Measure

Degree of Neuroinflammation [ Time Frame: Baseline reading only ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905-

Find similar trials in Rochester, MN

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
Mayo Clinic· Rochester, MN

Related Studies